Global Retirement Partners LLC purchased a new position in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 8,309 shares of the conglomerate's stock, valued at approximately $1,583,000.
Other large investors also recently bought and sold shares of the company. State of Wyoming acquired a new position in shares of Danaher in the second quarter worth about $74,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter valued at approximately $26,000. Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock worth $29,000 after buying an additional 53 shares in the last quarter. Finally, JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter worth $25,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Danaher Price Performance
Shares of DHR opened at $202.44 on Tuesday. The company has a market cap of $142.31 billion, a P/E ratio of 35.96, a PEG ratio of 2.52 and a beta of 0.78. The stock has a fifty day moving average price of $193.52 and a 200 day moving average price of $192.67. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. During the same period last year, the business posted $0.77 earnings per share. The firm's quarterly revenue was up 5.5% compared to the same quarter last year. On average, research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. Royal Bank Of Canada lifted their price target on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. Wolfe Research cut Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Finally, DZ Bank started coverage on Danaher in a research report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $228.91.
Get Our Latest Stock Report on Danaher
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.